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Abstract 
When a neutral stimulus is repeatedly paired with a drug, an association 
is established between them that can induce two different responses: either an 
opponent response that counteracts the effect of the drug, or a response that is 
similar to that induced by the drug. In this paper, we focus on the analysis of the 
associations that can be established between the contextual cues and the 
administration of dopamine agonists or antagonists. Our hypothesis suggests 
that repeated administration of drugs that modulate dopaminergic activity in the 
presence of a specific context leads to the establishment of an association that 
subsequently results in a conditioned response to the context that is similar to 
that induced by the drug. To test this hypothesis, we conducted two 
experiments that revealed that contextual cues acquired the property to 
modulate pre-pulse inhibition by prior pairings of such context with the 
dopamine antagonist haloperidol (Experiment 1), and with the dopamine agonist 
d-amphetamine (Experiment 2). The implications of these results are discussed 
both at a theoretical level, and attending to the possibilities that could involve 
the use of context cues for the therapeutic administration of dopaminergic 
drugs. 
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1. Introduction 
Classical conditioning has been considered for more than a century as 
one of the more flexible ways of learning used by those organisms with a 
complex nervous system in order to adapt to the demands of a continuously 
changing environment [1]. The implications of this type of learning have gone 
beyond the study of the processes by which the associations between stimuli 
are established, reaching areas such as the study of eating habits [2], emotional 
processes [3], or the analysis and treatment of some pathological behaviors [4], 
to mention only some of the most relevant applied areas in this field of research.  
One additional potential area of interest related to Pavlovian learning is 
the analysis of the associations that can be established between a neutral 
stimulus and the effects of certain drugs [5]. In this domain, two main fields of 
research can be identified: one that has led to results that show what has been 
called an "opponent process", by which the Conditioned Stimulus (CS) induces 
a response that is the opposite to that produced by the drug [6,7,8]. Conversely, 
a second set of results indicate that the association between a neutral stimulus 
and the drug results in a Conditioned Response (CR) similar to that produced 
by the drug [9,10].  
In an attempt to make compatible both sets of results, Eikelboom and 
Stewart [5] proposed that the functioning of the drug-response regulation 
system is based on a comparison between whether the drug has any direct 
effect or not in the central nervous system. From this perspective, a hypothetical 
response generator (or “integrator”) receives the inputs from the afferent or 
efferent arms of the feedback systems. Those physiological changes induced 
by the drug that access the response generator from an afferent neural path act 
as a signal to activate an effector that will be responsible for the observed drug 
effect. In such cases, the drug effect corresponds to an Unconditional 
Response (UR) that can be associated with a neutral stimulus to induce a CR 
that is similar to that induced by the drug. On the other hand, other drugs act on 
the efferent arm of the feedback system (affecting, for instance, the effector 
organ directly). The effect of such drugs cannot be considered as an UR, but 
the physiological changes induced by the drug may result in a signal to the 
response generator that will activate the efferent path to counteract the 
disturbance produced by the drug. Such an opposite response can in fact be 
considered from this perspective as an UR that could be associated with a 
neutral stimulus through an associative process. An example of this situation is, 
for instance, the hypothermia caused by ethanol [6,11]. Following Eikelboom & 
Stewart's proposal [5], ethanol directly acts on the efferent arm of the 
thermoregulatory system causing a drop in body temperature that acts as a 
signal for the response generator to activate an increase in body temperature 
through the effector’s activation. As a result of this process, a neutral stimulus 
associated with ethanol will result in a CR manifested as an increase in body 
temperature (a response that is opposite to the direct action of the drug).  
On the other hand, there have also been numerous studies of 
conditioning in which the stimuli associated with a drug elicited a CR that is 
similar to the direct effect of the drug. This area of research finds its most 
remote precedents in the work by Pavlov and his associates, who described a 
report in which, after several morphine injections, the mere presence of the 
context in which the drug was administered induced the same increase in the 
salivary response that was observed after morphine administration [12]. This 
study was pioneering in demonstrating that pairing the contextual cues with the 
drug administration can result in a conditioning process by which the context 
acts as a CS that mimics the effect of the drug. Subsequent studies using 
cocaine demonstrated that an association of the drug administration with a 
specific context resulted in an increase of the effects produced by the drug in 
the presence of the conditioned context [13,14]. Ross and Schnitzer [15] 
observed similar effects when injecting amphetamine into rats and, since then, 
there have been numerous experimental demonstrations of an augmentation in 
locomotor activity in the presence of a CS previously associated with 
amphetamine administration [16,17,18,19]. Considering the above-described 
proposal by Eikelboom and Stewart [5] it can be hypothesized that 
amphetamine administration is generating an increase of dopaminergic activity 
that would be the basis of the increase in the locomotor activity [20,21] that 
would be detected by the regulatory system through the afferent arm. 
Therefore, the action of amphetamine serves as an Unconditioned Stimulus 
(US) to increase dopamine activity (the UR), and the expected CR is in the 
same direction as the observed effect of amphetamine.  
In the following experiments we evaluated Prepulse Inhibition (PPI) in the 
presence of a context previously associated with the administration of a 
dopamine agonist (d-amphetamine) or antagonist (haloperidol). PPI is 
considered an example of sensory-motor gating, a process that impedes the 
processing of a stimulus in order to protect the processing of the stimulus that is 
already in progress [22], and can be easily reproduced in experimental 
conditions by presenting a low-intensity stimulus (typically a tone), named 
"Prepulse", for a short time (typically 80 -120 ms) preceding a stronger stimulus 
(called "Pulse"). The result is a reduction of the startle response to the pulse 
when it is preceded by the prepulse as compared to the pulse alone  [23,24]. 
PPI occurrence and intensity depend on several variables like the intensity of 
the stimuli presented [25,26], the length of the temporal interval between the 
prepulse and the pulse [25,27], or the intensity of the background noise [28,29].  
The physiological basis of PPI has been described in detail and, in 
particular, it seems to be modulated by several neurotransmitters including 
dopamine, GABA, glutamate, and acetylcholine, which regulate the magnitude 
of the startle response and its inhibition [23]. There is evidence demonstrating 
that dopamine-agonist administration results in a significant reduction of the PPI 
effect [30,31,32]. In addition, such dopamine-mediated PPI reduction is 
counteracted by the administration of haloperidol, a D2 and D3 dopamine 
antagonist [30], and the administration of haloperidol by itself has been shown 
to increase PPI [33]. 
Attending to the described results regarding drug conditioning, and PPI 
modulation by dopamine agonists, we propose that evaluating PPI in the 
presence of a context that had been repeatedly paired with a dopamine agonist 
or antagonist will result in a CR induced by the context that will modulate PPI 
intensity in the same way that the drug would do (namely, a PPI reduction with 
dopamine agonist and a reversion of the effect with dopamine antagonist). In 
order to test this hypothesis, we ran two experiments in which we associated a 
specific set of contextual cues with repeated administration of a dopamine 
agonist (d-amphetamine) or antagonist (haloperidol). In Experiment 1, one 
group received three pairings of a specific context and amphetamine injections, 
and a second group received the same number of pairings of the context with 
the administration of haloperidol prior to the amphetamine injection. In the test 
stage, all animals in both groups received a dose of amphetamine and PPI 
intensity was registered in the presence of the context previously associated 
with the corresponding drugs in order to be compared with PPI that had been 
registered before the start of the drug administration. In Experiment 2, for one 
group the context was associated with amphetamine administration and for a 
second group with haloperidol injections. During testing, PPI was evaluated in 
the presence of the corresponding conditioned context (in this case the animals 
were injected with a saline solution) in order to compare PPI intensity with that 
registered before the start of the experimental treatments. We used a PPI 
protocol previously validated in the absence of any drug treatment [34]. We 
added additional trials with 80 Db and 100 Db to the mentioned protocol in order 
to get a more ample range of PPI intensities. 
 
2. Experiment 1 
In this experiment, a group of rats received alternated i.p. amphetamine 
injections in the presence of a specific set of contextual cues, and haloperidol 
followed by d-amphetamine i.p. injections in the presence of a second different 
context. In the test stage, all animals were injected with amphetamine and PPI 
was evaluated both in the presence of the context associated with 
amphetamine and in the context associated with haloperidol + amphetamine. 
Context conditioning of dopaminergic activity would be demonstrated if PPI 
tested in the context associated with the dopamine agonist is lower as 
compared to PPI tested in the context paired with the dopamine antagonist. 
2.1 Method. 
2.1.1.Subjects. 
 
16 male Wistar rats (n=8) experimentally naïve, participated in this 
experiment. Mean weight at the start of the experiment was 336 g. (range 317-
394). Food and water were available ad libitum throughout the experiment. Rats 
were individually housed in the colony room with a regular light-dark cycle of 
12:12 hours. Four days before the start of the experimental sessions, each of 
the animals was handled 5 min daily. All procedures were conducted in 
accordance with the guidelines established by Directive 86/609/CEE of the 
European Community Council, and the Spanish R.D. 223/1988. 
2.1.2. Apparatus 
Four Panlab chambers (model LE 111) designed to detect and record 
the startle response in rats were used. Each chamber was enclosed in a 
soundproofed module (model LE 116), and inside each chamber a Plexiglas 
cylinder 8 cm in diameter was attached to the floor of the experimental 
chamber, resting on a platform that registered and recorded each animal´s 
movement. Vibrations of the Plexiglas enclosure caused by the whole-body 
startle response of the animal were converted into analog signals by a 
piezoelectric unit attached to the platform. These signals were digitized and 
stored by a computer as a linear parameter. The average startle activity was 
measured in a 100-ms time window starting at the onset of the sound stimulus.  
At the top of the camera there was a loudspeaker, which produced a 
constant background white noise of 65 dB. The pulse was a 20 ms, 120 dB 
white noise, and the pre-pulses were 20 ms, 80, 90, and 100 dB white noise. 
The lead interval for the prepulse-pulse trials was 100 ms, and intertrial interval 
between Pulse-alone and Prepulse-Pulse presentations was 30 sec (+/- 5). In 
order to get dissimilar contexts two different odors were used on each one (mint 
vs. almond). Additionally, for context A a 24V 2W keylight located in the left side 
of the chamber was switched on for the entire duration of each session, while it 
was switched off for context B. Amphetamine (3 mg/kg.) was dissolved in saline 
solution. Haloperidol (2 mg/Kg) was first dissolved in a few drops of acetic acid 
and then in 100 ml of saline (final pH: 6). 
2.1.3. Procedure 
For every animal, PPI was registered using the following protocol: Once 
the rats were introduced in the experimental chamber went through a 5-minute 
acclimation period in which the only auditory stimulation presented was the 
constant 65-dB SPL background noise, which remained throughout the 
experiment. After the acclimation period, 5 pulses were delivered in order to 
stabilize the startle response, with a mean ITI of 30 s. (+/-5). After 30 additional 
sec, 15 pulse-alone and 15 prepulse-pulse trials (5 with the 80 Db Prepulse, 5 
with the 90 Db Prepulse, and 5 with the 100 Db Prepulse) were presented in 
five blocks that included random presentation of 3 pulse-alone and three trials 
with each prepulse-pulse value. The ITI was 30 sec (+/- 5 sec). 
The effect of prepulses on the startle response was determined as the 
difference between responses in pulse-alone and prepulse-pulse trials, and 
expressed as percent PPI: PPI% = 100 x ([RP – RpP] / RP) where RP 
represents the average startle amplitude in Pulse-alone trials, and RpP 
indicates the average startle amplitude in prepulse-pulse trials, that was 
independently calculated for each prepulse value (80, 90, and 100 dB). The use 
of mean average startle amplitude collapsed across Pulse-alone trials in the 
formula was intended to avoid a possible effect of the higher number of Pulse-
alone trials (a total of 15) as compared to number of trials for each prepulse 
condition (5 for each intensity value). 
A summary of the experimental procedure is provided in the upper 
section of Table 1. In order to obtain a baseline of mean PPI in absence of 
drugs, PPI was registered for half of the animals in presence of Context A (mint-
light), and for the other half in presence of Context B (almond-dark). Thirty min 
before the start of each baseline PPI session the animals received an i.p. 
injection of saline (1 ml /Kg).  
----------------------------------------- 
Table 1 about here 
----------------------------------------- 
Context conditioning sessions were conducted in three blocks of 4 days 
each. In order to counterbalance contexts, for days 1 and 2 on each block half 
of the animals on each group received amphetamine in context A and 
Haloperidol + Amphetamine in context B. For the other half, the contexts were 
reversed on days 3 and 4. Therefore, on each 4-day block every animal 
received one association between the correspondent context and amphetamine 
and one pairing between the alternative context and haloperidol + 
amphetamine. In order to simplify the description of the procedure we will not 
make any additional reference to context counterbalancing.  
For the context-amphetamine trials each animal was i.p. injected with the 
drug and introduced in the experimental context and remained undisturbed for 
30 min. Next, the PPI protocol was initiated. For the haloperidol + amphetamine 
trials, haloperidol was i.p. injected, the animals were exposed to the 
corresponding context for 20 min, then they were injected with amphetamine, 
introduced in the context for an additional 30 min period, and finally exposed to 
the PPI protocol.  
Test stage was conducted on days 15 and 16. The first test day all rats 
received an amphetamine injection and were introduced in Context A (that had 
been associated with amphetamine for half of the animals and with 
amphetamine + haloperidol for the other half). After 30 min. without any 
additional manipulation the PPI protocol was initiated. The second test day was 
exactly as described except that it was conducted in Context B.  
 
2.2. Results 
A preliminary 3 x 2 mixed ANOVA (Prepulse Intensity: 80 vs. 90 vs. 100 
x Context: A vs. B, the first factor within-subject) was conducted on mean 
percent PPI during the first two days of the experiment (baseline). Only the 
main effect of Prepulse Intensity was significant, F(2,28)=4.27; p<.05 (all 
remaining ps>.23), revealing that the context differences did not differentially 
affect PPI. T-tests for related samples (p<.05, two-tailed) revealed that the main 
effect of prepulse intensity was due to a higher percent PPI in the 90 dB 
condition (mean = 56.43%, SD = 16.58) as compared to the 80 dB and 100 dB 
conditions (mean = 44.38%, SD = 20.13, and mean = 39.31%, SD = 21.42, 
respectively). 
To evaluate the effect of the drug administration on PPI intensity a 3 x 2 
ANOVA (Prepulse Intensity: 80 vs 90 vs 100 Db x Drug: Amphetamine vs. 
Haloperidol + amphetamine, both factors within-subject) was conducted on 
mean PPI collapsed across context conditioning sessions. The analysis 
revealed significant main effects of Prepulse Intensity and Drug main factors, 
F(2,30)=33.00; p<.001, and F(1,15)=33.58; p<.001, respectively. The 2-way 
interaction was non-significant, F(2,30)<1. T-tests for related samples (p<.05, 
two-tailed) revealed that the main effect of Prepulse Intensity was due to a 
higher overall percent PPI in the 90 dB (mean = 54.14%, SD = 11.21) as 
compared to the 80 dB and 100 dB conditions (mean = 36.84%, SD = 13.18, 
and mean = 28.18%, SD = 11.17, respectively). The main effect of Drug reflects 
the general reduction in percent PPI for those trials with amphetamine 
administration (mean = 26.48%, SD = 15.45) as compared to the haloperidol + 
amphetamine trials (mean = 45.98%, SD = 14.25, respectively).  
In order to evaluate the effect of context conditioning, a 3 x 3 ANOVA 
(Context test: Baseline vs. Amphetamine vs. Haloperidol + Amphetamine x 
Prepulse Intensity: 80 dB vs. 90 dB vs. 100 dB, both factors within-subject) was 
conducted on mean percent PPI during the baseline and testing days. The 
analyses revealed significant main effects of Context test and Prepulse 
intensity, F(2,30)=5.55; p<.01, and F(2,30)=21.23; p<.001, respectively. The 2-
way interaction was non-significant, F(4,60)<1. Pairwise comparisons (t-test for 
related samples, p<.05, two-tailed) revealed that the main effect of Prepulse 
Intensity was due to higher PPI for the 90 dB condition (mean = 49.32, SD = 
8.62) as compared to the 80 dB and 100 dB conditions (mean = 35.21, SD = 
11.52, and mean = 25.36, SD = 16.47, respectively).  
The main effect of Context test on PPI is depicted in Figure 1. As can be 
seen in the figure, PPI was reduced when the test was conducted in presence 
of the context associated with amphetamine as compared to the baseline day. 
However, PPI was reinstated in spite of amphetamine administration when 
tested in presence of the context previously associated with haloperidol + 
amphetamine injections. Pairwise comparisons between groups (t-test for 
related samples, one-tailed) revealed that PPI was reduced when comparing 
Baseline vs. Context amphetamine conditions, t(15)=4.07; p<.001, but remained 
intact when comparing Baseline vs. Context amphetamine + haloperidol, 
t(15)=1.40; p>.09. The difference between PPI measured in presence of 
Context amphetamine vs. Context haloperidol + amphetamine was close to the 
standard levels of significance, t(15)=1.71; p>.058. Finally, and in order to 
evaluate whether changes in PPI were related to variations in overall 
responding to the Pulse, an ANOVA was conducted on mean Startle to the 
pulse-alone trials with main factor Context test. The analysis revealed no 
significant differences, F(2,30)=1.89; p>.17.  
----------------------------------------- 
Figure 1 about here 
----------------------------------------- 
As predicted, the experimental results from the testing stage showed that 
the dopamine agonist reduced PPI when it was registered in the context 
previously associated with amphetamine as compared to baseline PPI [16,17]. 
Conversely, when PPI was registered in the presence of the context previously 
paired with haloperidol + amphetamine administration, it was expressed with 
the same intensity as in the drug-free baseline, in spite of the animals had been 
injected with amphetamine.  
 
3. EXPERIMENT 2 
The results of the first experiment revealed that the disruptive effect of 
amphetamine on PPI was counteracted when the sensory-motor gating effect 
was registered in the presence of the context previously paired with haloperidol 
+ amphetamine. We hypothesized that such a result was due to contextual 
conditioning of the dopaminergic activity, in such a way that context exposure 
induced a CR similar to the response activated by the dopamine antagonist. An 
alternative explanation of PPI modulation observed in Experiment 1 can be 
considered attending to a sensitization effect of the drug due to its repeated 
administration [35,36] Although the differences in PPI between the "Context 
amphetamine" and "Context amphetamine+haloperidol" conditions at testing 
argue against the sensitization hypothesis, testing was conducted in Experiment 
2 free of drug to discard a possible sensitization effect on PPI.  
 Thus, the main purpose of Experiment 2 was to replicate the PPI 
modulation by context conditioning of dopaminergic activity observed in 
Experiment 1, but introducing some procedural changes intended to control the 
effect of possible uncontrolled variables. Specifically, and in order to avoid a 
possible effect of repeated measures, PPI was registered only at baseline and 
test trials in this experiment. A second change consisted of administering just 
haloperidol in the dopamine antagonist-conditioning condition, instead of 
haloperidol and amphetamine, as we did in Experiment 1. More specifically, in 
this experiment we included two groups receiving context-amphetamine (Group 
Amph) vs. context-haloperidol pairings (Group Hal). Thirdly, the number of 
context-drug pairings was changed to six, instead of three as in Experiment 1, 
to increase the magnitude of the expected CR. Finally, and as mentioned 
above, we conducted the final test stage drug-free to avoid drug sensitization 
effects, to evaluate contextual conditioning without any direct physiological 
effect on the dopaminergic activity, and to control for the possible role of state-
dependent learning in the effects found in Experiment 1. According to the 
results of Experiment 1, we predict that the context associated with 
amphetamine will generate a conditioned increase in dopamine activation that 
will reduce PPI intensity as compared to that observed during the drug-free 
baseline. Conversely, we expect an increase of PPI [37,33] when tested in the 
presence of the context associated with the dopamine antagonist. 
3.1. Method 
3.1.1. Subjects 
16 male Wistar rats (n=8) experimentally naïve participated in this 
experiment. Mean weight at the start of the experiment was 426 g. (range 387-
504). Food and water were available ad libitum throughout the experiment. Rats 
were individually housed in the colony with a regular light-dark cycle of 12:12 
hours. Four days before the start of the experimental sessions, each of the 
animals was handled 5 minutes daily. All procedures were conducted in 
accordance with the guidelines established by Directive 86/609/CEE of the 
European Community Council, and the Spanish R.D. 223/1988. 
3.1.2. Apparatus  
The stimulus and apparatus were the same as described for Experiment 
1.  
3.1.3. Procedure  
A summary of the experimental design is represented in the lower 
section of Table 1. The protocol to registered PPI was the same as described 
for Experiment 1. In order to obtain an index of PPI without the action of any 
drug, PPI was registered after an injection of saline solution the first two days of 
the experiment. On day 1, half of the animals from the Group Amph, and half 
from the Group Hal were tested in Context A (mint/light). The second day, the 
other half of the rats on each group was tested for PPI in context B 
(almond/dark). Mean percent PPI on these sessions was considered as the 
baseline to compare with PPI at testing.  
As described for baseline, contexts were counterbalanced. However, in 
order to simplify the procedure description we will not make reference to the 
different contexts when describing the experimental manipulations.  
Context conditioning took place from day 3 to 26 and was organized in 4-
day blocks. On each block, the animals in the Amph and Hal groups received 
amphetamine or haloperidol injections in the corresponding context on days 1 
and 2. Immediately after drug administration, each animal was introduced in the 
conditioning context and remained undisturbed for 40 m. On days 3 and 4 of 
each 4-day block the rats were injected with a saline solution and introduced in 
the alternative context. This 4-day cycle was repeated for 6 times. PPI was 
measured after 3 and 6 context-drug pairings on days 3 and 4 of the cycle.  
3.2. Results 
A preliminary 3 x 2 x 2 mixed ANOVA (Prepulse intensity: 80 dB vs. 90 
dB vs. 100 dB x Context: A vs. B x Group: Amph vs. Hal, the first two variables 
being within-subjects) was conducted on mean percent PPI registered during 
the first two days of the experiment (baseline). No main effects or interactions 
were significant (all ps>.25). The lack of significance reveals that there were 
neither differences induced by the changes in contextual cues nor differences in 
baseline for the Groups that subsequently received amphetamine and 
haloperidol.  
In order to analyze the effect of context conditioning on PPI a 3 x 3 x 2 
mixed ANOVA (Prepulse intensity: 80 dB vs. 90 dB vs. 100 dB x Test Day: 
Baseline vs. Test 1 vs. Test 2 x Group: Amph vs. Hal) was conducted on mean 
percent PPI. The analysis revealed significant main effects of Prepulse intensity 
and Group, F(2,28)=10.21; p<.001, and F(1,14)=6.56; p<.05, respectively. T-
test for related samples (p<.05, two tailed) revealed that the main effect of 
Prepulse intensity was due to a lower mean PPI with the 100 dB prepulse 
(Mean = 40.35%, SD = 15.60) as compared to the 80 dB and 90 dB conditions 
(Mean = 52.76%, SD = 18.49, and Mean = 57.70%, SD = 17.30). The main 
effect of Group reflects lower PPI levels for those animals tested in the context 
paired with amphetamine as compared to those tested in the context associated 
with haloperidol (Mean = 42.22%, SD = 13.86, and Mean = 58.32%, SD = 
11.14, respectively). The Test day x Prepulse intensity interaction was also 
significant, F(4,56)=5.05; p<.01. A detailed inspection of the interaction revealed 
that it was due to a lower percent PPI with the 100 dB prepulse intensity in the 
Test 1 and Test 2 trials. Finally, the Test day x Group interaction was also 
significant, F(2,28)=4.26; p<.05. No more main effects or interactions were 
significant. 
The source of the Test day x Group interaction is depicted in Figure 2. As 
can be seen in the figure, mean percent PPI was reduced when registered in 
the context paired with amphetamine. Conversely, PPI increased when 
registered in presence of the context paired with haloperidol. These differences 
only appeared at second test trial. Specifically, t-test for independent samples 
(one-tailed) comparing mean percent PPI for Amph and Hal groups for Test 1 
(conducted after three context-drug pairings) revealed the absence of 
differences, t(14)=1.41; p=.09. For Test 2, after six context-drug pairings, PPI 
was more intense when tested in presence of the context previously paired with 
haloperidol than when it was tested in the amphetamine context, t(14)=3.59; 
p<.01. Additionally, we conducted within groups a priori comparisons based on 
our hypotheses (t-test for related samples, one-tailed). The analyses for the 
Group Amph revealed a significant reduction of PPI at test 2 as compared to 
test 1, t(7)=1.95; p<.05. There were no differences between PPI at baseline vs. 
test 1 or vs. test 2, t(7)<1, and t(7)=1.62; p=.074, respectively.  As for the 
comparisons for the context-haloperidol Group, in spite of trend of increased 
PPI at test 1 and 2 as compared to baseline than can be observed in Figure 2, 
the differences between baseline, test 1 and test 2 were non-significant (all 
ps>.08). Finally, to assess whether changes in PPI were due to changes in 
overall responding to the pulse, a mixed ANOVA with main factors Test day x 
Group was conducted on mean startle to the Pulse-alone trials. The analysis 
only revealed a significant main effect of Test day, F(2,28)=3.73; p<.05, due to 
a reduction of startle intensity on the first and second test trials as compared to 
the baseline day. Neither the main effect of Group nor the 2-way interaction was 
significant (both ps>.33), revealing that the effect of the experimental treatment 
on PPI was not due to changes in overall response to the Pulse. 
----------------------------------------- 
Figure 2 about here 
----------------------------------------- 
The results showed reduced PPI in the Amph as compared to the Hal 
group when PPI was registered in the conditioned context. This effect was 
restricted to the second test trial that took place after six context-drug pairings. 
Therefore, these results are consistent with those obtained in the first 
experiment, and add evidence to our proposal that dopamine activity can be 
modulated through a conditioning process.  
4. Discussion 
In summary, the present study demonstrated that a context repeatedly 
paired with a dopamine antagonist (Experiments 1) or with a dopamine agonist 
(Experiment 2) acquired the property to elicit a CR that is similar to that 
produced by the drug. In addition, we replicated the reduction of PPI by 
amphetamine administration [30,32], and the restoration of the amphetamine-
mediated PPI reduction by haloperidol [32]. More importantly, PPI remained 
intact in spite of amphetamine administration when it was tested in the context 
that had been paired with haloperidol + amphetamine in Experiment 1. This 
result indicates that the dopaminergic activity elicited by the dopamine 
antagonist was associated with the presence of the contextual cues in such a 
way that the context at testing produced a conditioned reduction in dopamine 
that counteracted the effect of amphetamine, and normalized the PPI effect. 
The results of Experiment 2 are consistent with this perspective, since PPI was 
slightly increased when measured drug-free in the contextual cues that had 
been associated with a dopamine antagonist, although the differences were 
non-significant. Conversely, PPI was significantly disrupted when tested drug-
free in the context that had been paired with the effects of the dopamine 
agonist.   
There is previous evidence on conditioned dopamine modulation in 
experiments that evaluate locomotor activity in contexts associated with 
amphetamine [16,18,20,35], or cocaine injections [39]. Thus, for instance, 
Beninger and Hahn [20] injected d-amphetamine (2.5 mg/Kg, i.p.) before 
introducing the rats in experimental chambers to register general activity. Next, 
the animals were injected with saline solution and returned to their home cages. 
In a control group, this treatment was reversed. When the animals were 
subsequently tested in the experimental chambers, those rats in the control 
group showed significantly less activity than those that had received the drug in 
the experimental chamber. A particularly relevant result in this domain was 
reported by Fontana Post & Pert [40], since they directly registered levels of 
dopamine after context conditioning. Specifically, they used the same procedure 
described above but injecting cocaine (40 mg/Kg) instead of amphetamine. At 
the behavioral level, they found an increase of rotational and stereotyped 
behaviors when the rats were tested in the context associated with the drug. At 
a physiological level, they found that exposing the animals to the conditioned 
context resulted in a dopamine increase in the Nucleus Accumbens 
extracellular space. Therefore, the described results, as well as our own 
experimental results, give strong support to the idea of conditioned-mediated 
increases and decreases of dopamine activity. 
Some authors have proposed an alternative non-associative account 
based on the effect of dopamine agonists on perceived context novelty for the 
results obtained in the experiments on dopamine conditioning [16,38]. 
Specifically, it has been repeatedly demonstrated that a new environment elicits 
exploratory responses that increases motor activity [41]. On the other hand, 
amphetamine administration impedes context habituation [42], therefore it might 
be that repeated amphetamine administration could be maintaining the context 
as functionally novel on every exposure, and this effect would be the basis of 
the proposed dopamine-mediated increase in motor activity. In an attempt to 
evaluate this possibility, Ahmed, Oberling, Di Scala and Sandner [38] 
introduced a phase of context familiarization before association with the 
contextual cues with the drug (1.25 mg/Kg amphetamine). The results revealed 
that, in spite of previous context familiarization, motor activity increased in the 
context-drug group as compared to the control group, thus discarding an 
explanation based exclusively on a context novelty interpretation. 
The non-associative hypothesis could also be relevant to our results and, 
more specifically, to those groups that received amphetamine, since there is 
evidence that a novel stimulus presented at the time of PPI evaluation can 
reduce the intensity of the startle-modulation phenomenon [34,43]. As PPI in 
our experiments was registered at the test stage in the context that had been 
consistently presented after amphetamine injections, and amphetamine 
prevents context novelty habituation, it is possible that context novelty was the 
basis of reduced PPI. As discussed by Schmajuk, Larrauri, De la Casa and 
Levin [43], this reduction can be related to an increase in dopaminergic activity 
in the Nucleus Accumbens elicited by the novel environment [44].  
However, there are several facts that rule out such a non-associative 
interpretation of our experimental results (particularly those from Group Amph in 
Experiment 2): first, if the novelty-based hypothesis is correct, we would expect 
reduced PPI in all groups from Experiment 1, because the test stage was 
conducted under the effects of amphetamine. However, we obtained exactly the 
opposite result when the test was conducted in the presence of the context 
associated with haloperidol + amphetamine. Secondly, the non-associative 
hypothesis cannot explain the intact PPI observed in Experiment 2 for the Amph 
Group after three context-drug pairings (see Figure 2), because at this time the 
context novelty should be higher than after six pairings and, therefore, context 
novelty should be promoting reduced PPI.  
In the introduction, we described the hypothesis proposed by Eikelboom 
and Stewart [5] that tries to make compatible the conflicting results observed in 
the analysis of drug conditioning (CR similar or opposite to the physiological 
effects of the drugs). According to this proposal, the results from our study 
indicate that both amphetamine and haloperidol produced their effects by an 
action on an efferent arm of the dopaminergic system, assuming that the 
changes observed in PPI were the result of increments or decrements in 
dopamine activity [23]. However, there is also previous research examining 
conditioning with amphetamine and haloperidol as an US that resulted in 
opponent or compensatory responses. Thus, for instance, Poulos, Wilkinson, 
and Cappell [45] conducted a series of experiments examining tolerance to 
amphetamine-induced anorexia that revealed the occurrence of a 
compensatory CR that counteracted the drug effect when it was administered in 
the same context associated with the drug administration. Similarly, tolerance to 
haloperidol-induced catalepsy in rats was observed only when the animals were 
exposed to the context previously associated with the drug [46]. Therefore, the 
different conditioned reactions to the same drug can be interpreted as an 
adaptive response produced to increase the survival of the organism, and the 
differences detected seem to be related to the specific responses selected on 
each experimental situation. 
 The present findings have implications for the therapeutic use of 
dopaminergic drugs, and more specifically, for adjustment of the appropriate 
dose of antipsychotic drugs in psychiatric patients [47]. There are a large 
number of side effects of new and traditional neuroleptic drugs [48,49,50]. 
Considering the role of classical conditioning to generate a CR that mimics the 
effect of the drug, we can predict that maintaining constant all internal and 
external cues present at the time of treatment, an associative process will 
develop that activates anticipatory CRs similar to those induced for the drug. An 
appropriate schedule of conditioning, alternating context-drugs and context-
placebo trials, could be programmed to reduce the drug dose but maintaining 
the therapeutic effectiveness of treatment.  
Future studies are necessary to directly evaluate changes in dopamine 
levels in the presence of the CS associated with the drug. There is experimental 
evidence of a conditioned increase in extracellular dopamine after context-
cocaine association [40], and higher concentrations of the dopamine metabolite 
homovanillic acid in mesolimbic and caudate regions after context-
amphetamine and context-apomorphine pairings as compared to pseudo-
conditioned control groups [51]. However, there are also conflicting results 
indicating no change in dopamine metabolite concentrations using cocaine as 
the CS [52]. Hopefully, understanding how the neuropsychological mechanisms 
are activated by both drug action and environmental associations will provide 
new strategies to approach the treatment of psychiatric syndromes 
characterized by malfunctioning of the dopaminergic system.  
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Table 1. Summary of the design for Experiment 1 (upper section), and for 
Experiment 2 (lower section). A and B refer to two separate contexts 
(counterbalanced). Amph: Amphetamine. Hal: Haloperidol. PPI was registered 
during all sessions for Experiment 1. For Experiment 2 PPI was registered at 
Baseline, and after third and sixth conditioning trials. See text for additional 
details 
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Figure captions. 
 
 
Figure 1: Mean percent PPI collapsed across trials measured at the 
baseline session (with the animals injected with saline solution) and for those 
sessions conducted in presence of the context associated with amphetamine 
and the context associated with haloperidol + amphetamine (the animals 
received an amphetamine dose before the test trial). Error bars represent 
SEMs. 
 
Figure 2: Mean percent PPI collapsed across trials as a function of 
context-drug conditioning (amphetamine vs drug) for Baseline, first test trial 
(after three context-drug pairings) and second test trial (after six context-drug 
trials). All tests were conducted without drugs. Error bars represent SEMs. 
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